Risk factors and prevalence of bone disease in inflammatory bowel disease
- 1 January 2000
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or OlderNew England Journal of Medicine, 1997
- Relationships between vitamin D, parathyroid hormone and bone mineral density in inflammatory bowel diseaseJournal of Internal Medicine, 1996
- Metabolic bone assessment in patients with inflammatory bowel diseaseGastroenterology, 1995
- Estrogen status and heredity are major determinants of premenopausal bone mass.Journal of Clinical Investigation, 1992
- Low bone mineral density in patients with inflammatory bowel diseaseDigestive Diseases and Sciences, 1992
- Longitudinal Study of Cortical Bone Loss in Patients with Inflammatory Bowel DiseaseScandinavian Journal of Gastroenterology, 1992
- Cigarette Smoking, Serum Estrogens, and Bone Loss during Hormone-Replacement Therapy Early after MenopauseNew England Journal of Medicine, 1985
- Glucocorticoid-Induced OsteoporosisNew England Journal of Medicine, 1983
- Steroid-Induced Fractures and Bone Loss in Patients with AsthmaNew England Journal of Medicine, 1983
- The effect of supplemental oral phosphate on the bone mineral changes during prolonged bed restJournal of Clinical Investigation, 1971